Characterizing the Epidemiology of Cannabidiol (CBD) Use Among US adults

项目摘要/摘要 该项目将直接推进NIDA的战略目标，即“增强对现实的了解-- 毒品使用的世界景观。本项目的培训活动将包括：1.获取 大麻产品作为一种药物被探索的方式的基础知识 产品以及如何对其进行监管。(TG1)；2.发展基本技能和知识 需要应用文本分析的自然语言处理(NLP)方法。(Tg2)； 进一步发展成为一名独立的物质使用研究人员所需的一般技能， 包括对使用人群进行物质研究的道德行为、赠款、手稿 写作、向立法者进行政策简报和陈述，以及跨学科研究(TG3)。这个 这项K01的研究是为了描述美国成年人(18岁以上)使用CBD的流行病学特征。一个 单次调查(目标n=1500)将完成以下具体研究目标：1. 描述CBD用户的特征(目标1)，2.描述CBD作为替代或 与其他药物相辅相成。(目标2)，和3.自我报告的CBD相关不良反应的特征 活动(目标3)。这项研究及其未来应用的所有方面都将得到加强 增加了我对大麻调节(Tg1)和NLP(Tg2)的理解。传播 这些项目的活动包括同行评议出版物、会议和专题讨论会。 并制定政策简报和向州立法机构提交的报告。

Project Summary/Abstract This project will directly advance the NIDA strategic objectives to “enhance knowledge of the real- world landscape of drug use.” The training activities of this project will include: 1. Acquire foundational knowledge of the way that cannabis products have been explored as a medicinal product and how they are regulated. (TG1); 2. Develop the fundamental skills and knowledge required to apply natural language processing (NLP) approaches of text analysis. (TG 2); and 3. Further develop the general skills needed to be an independent substance use researcher, including ethical conduct of research for substance using populations, grantsmanship, manuscript writing, policy briefing and presentation to legislators, and cross-disciplinary research (TG3). The research of this K01 is to characterize epidemiology of CBD use among US adults (18+ years). A single survey (target n=1500) will be used complete the following specific research aims: 1. Describe the characteristics of CBD users (Aim 1), 2. Characterize CBD use as a substitute or adjunct to other medications. (Aim 2), and 3. Characterize self-reported CBD-related adverse events (Aim 3). All aspects of this research and its future applications will be enhanced by the growth in my understanding of cannabis regulation (TG 1) and NLP (TG 2). Dissemination activities for the projects include peer-review publications, conference and symposium presentations, and developing policy briefings and presentations to state legislature.